Company / Revenue per Share
Bone Biologics Corp Revenue per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$34.87
FY2020
5-year range
$27.56 / $247.22
FY2017-FY2020
Trend
-13.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $247.22 to $34.87 over the past 2 years.
Based on SEC 10-K filings.
34.87 in FY2020 with a 3-year CAGR of +8.2%.
Declined from $247.22 to $34.87 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +8.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, revenue per share decreased 13.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $34.87 | -13.8% |
| FY2019 | $40.46 | -83.6% |
| FY2018 | $247.22 | +797.1% |
| FY2017 | $27.56 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026